The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome
Abstract
Most of the small number of cases of poliomyelitis which occur in countries where Sabin's attenuated poliovirus vaccines are used are temporally associated with administration of vaccine and involve polioviruses of types 2 and 3 (ref. 1). Recent studies have provided convincing evidence that the Sabin type 2 and 3 viruses themselves may revert to a neurovirulent phenotype on passage in man. We report here that a point mutation in the 5' noncoding region of the genome of the poliovirus type 3 vaccine consistently reverts to wild type in strains isolated from cases of vaccine-associated poliomyelitis. Virus with this change is rapidly selected on passage through the human gastrointestinal tract. The change is associated with a demonstrable increase in the neurovirulence of the virus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Soon after vaccination, the majority of vaccinees shed polioviruses with a high frequency of such mutations (Evans et al., 1985, Stern et al., 2017), indicating that the structural stability of domV is under strong positive selection in the human gut.”
From Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence (2020) · cites this paper as Evans et al., 1985
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Complete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 418
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
Nomoto, A., Omata, T., Toyoda, H., Kuge, S., Horie, H., Kataoka, Y., Genba, Y., Nakano, Y., & Imura, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.5793 · Cited by 308
The complete nucleotide sequence of a common cold virus: human rhinovlrus 14
Stanway, G., Hughes, P. J., Mountford, R. C., Minor, P. D., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7859 · Cited by 254
Self-citationStanway, G., Hughes, P. J., Mountford, R. C., Reeve, P., Minor, P. D., Schild, G. C., & Almond, J. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1539 · Cited by 188
Self-citationSome simple computational methods to improve the folding of large RNAs
Jacobson, A. B., Good, L., Simonetti, J., & Zuker, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.45 · Cited by 164
Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans
Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H., & Obijeski, J. F. (1981) · Journal of General Virology · doi:10.1099/0022-1317-56-2-337 · Cited by 149
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine
Cann, A. J., Stanway, G., Hughes, P. J., Minor, P. D., Evans, D. M. A., Schild, G. C., & Almond, J. W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.20.7787 · Cited by 146
Self-citationCritical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3
Evans, D. M. A., Minor, P. D., Schild, G., & Almond, J. W. (1983) · Nature · doi:10.1038/304459a0 · Cited by 111
Self-citationComparative biochemical studies of type 3 poliovirus
Minor, P. D. (1980) · Journal of Virology · doi:10.1128/jvi.34.1.73-84.1980 · Cited by 79
Self-citation
Research works printed but not linked: 2
- Assaad, F. & Cockburn, W. C. Bull Wld Hlth Org. 60, 231–242 (1982).
- Tech. Rep. Ser. Wld Hlth Org. 687, 134 (1983).
Cited by
Items 201–300 of 438
Yanagiya, A., Ohka, S., Hashida, N., Okamura, M., Taya, C., Kamoshita, N., Iwasaki, K., Sasaki, Y., Yonekawa, H., & Nomoto, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10479-10487.2003 · Cited by 35
“An effective mutation of the neurovirulence phenotype of PV was first described for PV type 3 by comparative sequence analysis between the attenuated Sabin 3 and its neurovirulent revertants (6).”
BackgroundMartin, A., Bénichou, D., Couderc, T., Hogle, J. M., Wychowski, C., van der Werf, S., & Girard, M. P. (1991) · Virology · doi:10.1016/0042-6822(91)90078-p · Cited by 35
Emergency Services of Viral RNAs: Repair and Remodeling
Agol, V. I., & Gmyl, A. P. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00067-17 · Cited by 38
Tissue tropism of recombinant coxsackieviruses in an adult mouse model
Harvala, H., Kalimo, H., Bergelson, J. M., Stanway, G., & Hyypiä, T. (2005) · Journal of General Virology · doi:10.1099/vir.0.80603-0 · Cited by 36
“Attenuating mutations of PVs (nt 480, 481 and 472 in types 1, 2 and 3, respectively; Evans et al., 1985; Gromeier et al., 1999; Minor, 1992; Ren et al., 1991; Svitkin et al., 1990) have been mapped to stem–loop V of the internal ribosomal entry site (IRES), which is responsible for ribosome binding…”
BackgroundSelf-citationAnatomy of the Poliovirus Internal Ribosome Entry Site
Ehrenfeld, E., & Semler, B. L. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79663-0_3 · Cited by 34
Bandyopadhyay, P. K., Wang, C., & Lipton, H. L. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6249-6256.1992 · Cited by 35
“For poliovirus, it was shown that mutation of a single base in the 5'UTR was important in determining virus growth and neurovirulence (10, 40, 46).”
BackgroundConstruction of poliovirus intertypic recombinants by use of cDNA
Stanway, G., Hughes, P. J., Westrop, G. D., Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., & Almond, J. W. (1986) · Journal of Virology · doi:10.1128/jvi.57.3.1187-1190.1986 · Cited by 34
Self-citationPoliovirus Vaccines: Molecular Biology and Immune Response
Minor, P. D., & Almond, J. (2014) · Molecular Biology of Picornavirus · doi:10.1128/9781555817916.ch30 · Cited by 33
Self-citationYamayoshi, S., Fujii, K., & Koike, S. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00032 · Cited by 38
“Herein, we will summarize the importance of scavenger receptor class B, member 2 (SCARB2) as a receptor for EV71.”
BackgroundParisi, J. M., Giomi, P. C., Grigera, P. R., de Mello, P. A., Bergmann, I. E., TORRE, J. L. L., & Scodller, E. A. (1985) · Virology · doi:10.1016/0042-6822(85)90227-2 · Cited by 33
Oleksiewicz, M. B., Bøtner, A. G., Nielsen, J. P., & Storgaard, T. (1999) · Archives of Virology · doi:10.1007/s007050050560 · Cited by 33
“Furthermore, the 5 ′-leaders appears to be a highly mobile genetic element, able of high-efficiency recombination between related viruses [11], and 5 ′-leaders of other RNA viruses such as poliovirus and Venezuelan Equine Encephalitis virus contain attenuation/virulence determinants [5,8].”
BackgroundEnteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine
Drescher, K. M., von Herrath, M., & Tracy, S. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1815 · Cited by 37
RNA-Binding Proteins as Regulators of Internal Initiation of Viral mRNA Translation
López‐Ulloa, B., Fuentes, Y., Pizarro-Ortega, M. S., & López‐Lastra, M. (2022) · Viruses · doi:10.3390/v14020188 · Cited by 38
Feuer, R., & Whitton, J. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-75546-3_7 · Cited by 32
Paralytic Poliomyelitis Associated With Sabin Monovalent and Bivalent Oral Polio Vaccines in Hungary
Estívariz, C. F., Molnar, Z., Venczel, L., Kapusinszky, B., Zingeser, J. A., Lipskaya, G. Y., Kew, O. M., Berencsi, G., & Csohan, A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr070 · Cited by 31
“As reported previously (41), all isolates had the U472C mutation within the 5#-untranslated region associated with reversion to neurovirulence (42, 43), but none had more than 1% ( 10 nucleotide substitutions) viral protein 1 sequence divergence indicative of prolonged replication or circulation (44).”
BackgroundZhang, H., Morgan-Capner, P., Latif, N., Pandolfino, Y. A., Fan, W., Dunn, M. J., & ARCHARD, L. C. (1997) · Europe PMC (PubMed Central) · Cited by 34
Translation and Protein Processing
Martínez-Salas, E., & Ryan, M. D. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch9 · Cited by 30
Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge
Hunziker, I. P., Harkins, S., Feuer, R., Cornell, C. T., & Whitton, J. L. (2004) · Virology · doi:10.1016/j.virol.2004.09.035 · Cited by 30
Yang, S. X., Kwang, J., & Laegreid, W. W. (1998) · Archives of Virology · doi:10.1007/s007050050316 · Cited by 29
“This mutation reduces neurovirulence in a standard WHO neurovirulence test [6].”
BackgroundHepatitis A virus: Insights from molecular biology
Cohen, J. I. (1989) · Hepatology · doi:10.1002/hep.1840090617 · Cited by 29
Wen, H., Si, L.-Y., Yuan, X., Hao, S., Gao, F., Chu, F.-L., Sun, C., & Wang, Z. (2013) · Virology Journal · doi:10.1186/1743-422x-10-115 · Cited by 28
“Nucleotide 480, 481 and 472 on 50-UTR of poliovirus were identified as neurovirulence determinants of poliovirus [19-21].”
BackgroundComparative Genomics of the Coxsackie B Viruses and Related Enteroviruses
Oberste, M. S. (2008) · Springer eBooks · doi:10.1007/978-3-540-75546-3_2 · Cited by 36
“A number of mutations that attenuate the cardiovirulent phenotype of certain CVB3 strains or the neurovirulence of polioviruses have been mapped to the 5¢-NTR (Dunn et al. 2000, 2003; Evans et al. 1985; Kawamura et al. 1989; Macadam et al. 1991) (see also the chapter by K. Knowlton).”
BackgroundKobiler, D., Rice, C. M., Brodie, C., Shahar, A., Dubuisson, J., Halevy, M., & Lustig, S. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10440-10446.1999 · Cited by 28
Sagedahl, A., Giraudo, A. T., de Mello, P. A., Bergmann, I. E., Torre, J. L., & Scodeller, E. A. (1987) · Virology · doi:10.1016/0042-6822(87)90279-0 · Cited by 28
Contreras, G., Dimock, K., Furesz, J., Gardell, C., Hazlett, D., Karpinski, K., McCorkle, G., & Wu, L. (1992) · Biologicals · doi:10.1016/s1045-1056(05)80003-x · Cited by 27
Kok, C. C., Phuektes, P., Bek, E. J., & McMinn, P. C. (2011) · Journal of Virology · doi:10.1128/jvi.00069-11 · Cited by 27
Bradrick, S. S., Lieben, E. A., Carden, B. M., & Romero, J. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6472-6481.2001 · Cited by 28
“A wealth of experimental data indicate that the PV 5 NTR is the major determinant of the virulence phenotype (17, 32, 41).”
BackgroundBuonagurio, D. A., Coleman, J. W., Patibandla, S. A., Prabhakar, B. S., & Tatem, J. M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.2.283-289.1999 · Cited by 29
Equestre, M., Genovese, D., Cavalieri, F., Fiore, L., Santoro, R., & Bercoff, R. P. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2707-2710.1991 · Cited by 27
Nucleic acid sequence relationships between enterovirus serotypes
Hyypiä, T., Maaronen, M., Auvinen, P., Stålhandske, P., Pettersson, U., Stanway, G., Hughes, P., Ryan, M. D., Almond, J. W., Stenvik, M., et al. (1987) · Molecular and Cellular Probes · doi:10.1016/0890-8508(87)90025-9 · Cited by 27
Self-citationAre known pyrogenic cytokines responsible for fever in influenza?
Price, G. E., Fenton, R. J., Smith, H. C., & Sweet, C. (1997) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199707)52:3<336::aid-jmv17>3.0.co;2-g · Cited by 16
Molecular aspects of poliovirus pathogenesis
Nomoto, A. (2007) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.83.266 · Cited by 31
Production of Poliovirus Vaccines: Past, Present, and Future
DUCHENE, M., Peetermans, J., D'Hondt, E., Harford, N., FABRY, L., & Stéphenne, J. (1990) · Viral Immunology · doi:10.1089/vim.1990.3.243 · Cited by 28
Comparative Evaluation of Immunization with Live Attenuated and Inactivated Poliovirus Vaccines
Ogra, P. L. O. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44442.x · Cited by 26
Georgescu, M., Tardy-Panit, M., Guillot, S., Crainic, R., & Delpeyroux, F. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5278-5286.1995 · Cited by 28
Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome
Ramsingh, A. I., Hixson, A., Duceman, B. W., & Slack, J. K. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.3078-3081.1990 · Cited by 25
“Studies on poliovirus suggest that the neurovirulent phenotype maps to the 5' UTR (1), while studies on Theiler's murine encephalomyelitis virus suggest that the disease phenotype maps to the VOL.”
BackgroundResultVaccine-associated cases of poliomyelitis over a 30 year period in East Germany
Driesel, G., Diedrich, S., Künkel, U., & Schreier, E. (1995) · European Journal of Epidemiology · doi:10.1007/bf01720298 · Cited by 25
Quantitative aspects of the mutant analysis by PCR and restriction enzyme cleavage (MAPREC).Preprint
Lu, Z., Douthitt, M., Taffs, R. E., Ran, Y., Norwood, L. P., & Chumakov, K. (1993) · Genome Research · doi:10.1101/gr.3.3.176 · Cited by 25
Rowe, A., Ferguson, G. L., Minor, P. D., & Macadam, A. J. (2000) · Virology · doi:10.1006/viro.2000.0244 · Cited by 24
Self-citationYogarajah, T., Ong, K. C., Perera, D., & Wong, K. T. (2017) · Journal of Virology · doi:10.1128/jvi.01914-17 · Cited by 24
Stein, S., Zhang, L., & Roos, R. P. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4508-4517.1992 · Cited by 25
“A single nucleotide change in the 5' UTR of poliovirus Sabin type 3 can function as the sole determinant of attenuation (11).”
BackgroundMolecular basis of vaccination
Giudice, G. D., Pizza, M., & Rappuoli, R. (1998) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(98)00002-8 · Cited by 27
Ross, B. C., Anderson, B. N., Edwards, P. C., & Gust, I. D. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-10-2805 · Cited by 24
Poliomyelitis and Poliovirus Immunization
Modlin, J. F. (2014) · ASM Press eBooks · doi:10.1128/9781555818326.ch9 · Cited by 24
Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Wakabayashi, K., Nomoto, A., & Hashizume, S. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10224 · Cited by 24
Martinez, C. V., Old, M. O., Kwock, D., Khan, S. S., García, J. J., Chan, C. S., Webster, R. L., Halpern, M. S., & Maldonado, Y. (2004) · The Journal of Infectious Diseases · doi:10.1086/421703 · Cited by 23
Can Enteroviruses Cause Type 1 Diabetes?
Tauriainen, S., Salminen, K., & Hyöty, H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1288.003 · Cited by 24
Vaccine-Associated Paralytic Poliomyelitis
Querfurth, H. W. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530050061013 · Cited by 23
Blomqvist, S., Savolainen‐Kopra, C., Paananen, A., Bassioni, L. E., Nasr, E. M. E. M., Firstova, L., Zamiatina, N. A., Kutateladze, T., & Roivainen, M. (2010) · Virus Research · doi:10.1016/j.virusres.2010.05.006 · Cited by 25
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00048-1 · Cited by 33
Mangada, M. N. M., & Igarashi, A. (1997) · Virus Genes · doi:10.1023/a:1007914520454 · Cited by 22
Complete nucleotide sequence of a beta‐cell tropic variant of coxsackievirus B4
Titchener, P. A., Jenkins, O. F., Szopa, T. M., Taylor, K. W., & Almond, J. W. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890420408 · Cited by 22
Self-citationTatem, J. M., Weeks-Levy, C., Mento, S. J., Dimichele, S. J., Georgiu, A. F., Waterfield, W. F., Sheip, B., Costalas, C., Davies, T., Ritchey, M. B., et al. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350206 · Cited by 22
Willian, S., Tracy, S., Chapman, N. M., Leser, S., Romero, J., Shapiro, B. A., & Currey, K. M. (2000) · Archives of Virology · doi:10.1007/s007050070040 · Cited by 22
“The key attenuating site in the Sabin vaccine poliovirus types 1–3 (PV1–3) strains [22–24] reviewed in [25] is a transition in the 5 ′ NTR of each viral genome [22, 26, 27].”
BackgroundSelf-citationStudies on the attenuation of the Sabin type 3 oral polio vaccine
Almond, J. W., Westrop, G. D., Evans, D. M. A., Dunn, G., Minor, P. D., Magrath, D. I., & Schild, G. C. (1987) · Journal of Virological Methods · doi:10.1016/0166-0934(87)90081-4 · Cited by 21
Self-citationPevear, D. C., Oh, C. K., Cunningham, L. L., Calenoff, M. A., & Jubelt, B. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-1-43 · Cited by 21
“Two specific bases in this region of the PV3 genome have been implicated in neurovirulence, base 472 (Evans et al., 1985) and bases 220 and 472 (La Monica et al., 1987a).”
BackgroundConditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA
Kirkegaard, K., & Nelsen, B. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.1.185-194.1990 · Cited by 21
“noncoding region causes pronounced changes in the neurovirulence of type III poliovirus (14).”
BackgroundDeterminants of Poliovirus Pathogenesis
Gromeier, M., & Nomoto, A. (2014) · Molecular Biology of Picornavirus · doi:10.1128/9781555817916.ch29 · Cited by 20
Kapusinszky, B., Molnár, Z., Szomor, K. N., & Berencsi, G. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00621.x · Cited by 21
Stewart, S. R., & Semler, B. L. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.23.5318 · Cited by 20
Hepatitis A Virus and Hepatitis A Infection
Ross, B. C., Anderson, D. A., & Gus, I. D. (1991) · Advances in virus research · doi:10.1016/s0065-3527(08)60796-4 · Cited by 20
Tang, J., Hantz, O., Vitvitski, L., Lamelin, J. P., Paraná, R., Cova, L., Lesbordes, J. L., & TREPO, C. G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-9-1827 · Cited by 20
Toward replacement of the monkey neurovirulence test in vaccine safety testing
Rubin, S. A. (2011) · Procedia in Vaccinology · doi:10.1016/j.provac.2011.10.027 · Cited by 19
Currey, K. M., & Shapiro, B. A. (1997) · Computer applications in the biosciences · doi:10.1093/bioinformatics/13.1.1 · Cited by 20
Self-citationJahan, N., Wimmer, E., & Mueller, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060791 · Cited by 20
“IRESomes may confer tissue tropism to a virus [14], [15], [16], [17], [18], [9], [19], [20].”
BackgroundRisks connected with the use of conventional and genetically engineerd vaccines
Kimman, T. G. (1992) · Veterinary Quarterly · doi:10.1080/01652176.1992.9694344 · Cited by 18
Nathanson, N., & Horn, S. D. (1992) · Vaccine · doi:10.1016/0264-410x(92)90396-2 · Cited by 18
Santagati, M. G., Määttä, J. A., Röyttä, M., Salmi, A. A., & Hinkkanen, A. (1998) · Virology · doi:10.1006/viro.1998.9031 · Cited by 18
“In addition to the structural proteins, mutation(s) or deletion(s) in the nontranslated regions (NTR(s)) of the RNA genome have been shown to alter the virulence, probably by affecting the replication or translation of the viral genome (Evans et al., 1985; Kinney et al., 1993; Kuhn et al., 1992).”
BackgroundGenetically defined variants of hepatitis B virus
Carman, W. F., & Thomas, H. C. (1991) · Reviews in Medical Virology · doi:10.1002/rmv.1980010108 · Cited by 18
Gnanashanmugam, D., Halpern, M. S., Dodge, A., Fang, M., Wong, L. J., Esparza, M., Hammon, R. J., Rivas-Merelles, E. E., Santos, J. I., & Maldonado, Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-06 · Cited by 17
“Real-time PCR offers a rapid and efficient method of detecting OPV and its associated reversion, and this method can be used to assess the risk of VAPP and VDPV outbreaks in communities which continue to use OPV.”
BackgroundInfluentialSobsey, M. D., & Pillai, S. D. (2009) · Journal of Water and Health · doi:10.2166/wh.2009.096 · Cited by 18
“(Evans et al. 1985; Racaniello 2006; De Jesus 2007).”
BackgroundPoliovirus proves IRES-istible in vivo
Semler, B. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22139 · Cited by 22
Chezzi, C., Dommann, C. J., Blackburn, N. K., Maselesele, E., McAnerney, J., & Schoub, B. D. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00079-6 · Cited by 19
Cao, X., Bergmann, I. E., & Beck, E. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-11-2821 · Cited by 17
Sarnow, P., Jacobson, S. J., & Najita, L. (1990) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75602-3_6 · Cited by 17
Isbrucker, R. A., Levis, R., Casey, W., McFarland, R., Schmitt, M. P., Arciniega, J. L., DESCAMPS, J., Finn, T. M., Hendriksen, C. F. M., Horiuchi, Y., et al. (2011) · Procedia in Vaccinology · doi:10.1016/j.provac.2011.10.004 · Cited by 18
Glass, M. J., & Summers, D. F. (1992) · Virus Research · doi:10.1016/0168-1702(92)90143-w · Cited by 17
Mechanisms Controlling Virulence Thresholds of Mixed Viral Populations
Lancaster, K. Z., & Pfeiffer, J. K. (2011) · Journal of Virology · doi:10.1128/jvi.00355-11 · Cited by 19
“Additionally, a high percentage of healthy vaccinated infants excrete the type 3 Sabin virus, and nearly all of these isolates had undergone a reversion of the single major attenuating mutation in this virus, yet these infants did not develop disease (22, 44, 45).”
BackgroundMackiewicz, V., Cammas, A., Desbois, D., Marchadier, E., Pierredon, S., Beaulieux, F., Dussaix, É., Vagner, S., & Roque‐Afonso, A. (2010) · Journal of Virology · doi:10.1128/jvi.02598-09 · Cited by 16
“The role of IRES mutations in virulence or tissue tropism of picornavirus has been reported but is still a source of debate (10, 19).”
BackgroundProblems and Prospects for Preparation of Killed Antiviral Vaccines
BUDOWSKY, E. I. (1991) · Advances in virus research · doi:10.1016/s0065-3527(08)60797-6 · Cited by 16
Evans, S. A., Baron, M. D., Chamberlain, R. W., Goatley, L. C., & Barrett, T. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-12-3611 · Cited by 16
Santagati, M. G., Itäranta, P., Koskimies, P., Määttä, J. A., Salmi, A. A., & Hinkkanen, A. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-6-1499 · Cited by 16
“5' NTR is a major determinant of neuropathogenicity (Evans et al., 1985; Omata et al., 1986).”
BackgroundJohnson, K. L., & Sarnow, P. (2014) · ASM Press eBooks · doi:10.1128/9781555818326.ch4 · Cited by 16
The 5′ untranslated region as a pathogenicity determinant of Semliki Forest virus in mice
Logue, C. H., Sheahan, B. J., & Atkins, G. J. (2008) · Virus Genes · doi:10.1007/s11262-008-0209-1 · Cited by 15
Yogarajah, T., Ong, K. C., Perera, D., & Wong, K. T. (2016) · Archives of Virology · doi:10.1007/s00705-016-3157-4 · Cited by 16
Mallet, L., Pelloquin, F., Brigaud, M., Caudrelier, P., Bandet, R., Xueref, C., Fuchs, F., Gibelin, N., Goldman, C., Moulin, J.-C., et al. (1997) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199705)52:1<97::aid-jmv16>3.0.co;2-y · Cited by 15
Neurovirulence of Type 1 Polioviruses Isolated from Sewage in Japan
Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Ota, Y., Nakayama, T., Doi, Y., & Hashizume, S. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.1.138-142.2002 · Cited by 15
“... demonstrated that neurovirulence increased when the following changes took place in base positions of the viruses: in type 1 viruses, position 480 in the 5 noncoding region changed from G to A (12, 15); position 525, which is base paired with position 480 in a stem and loop structure of the F-domain (26), changed…”
BackgroundThe Primary Viruses of Myocarditis
Kim, K.-S., Höfling, K., Carson, S. D., Chapman, N. M., & Tracy, S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-319-4_2 · Cited by 17
Souii, A., M’hadheb-Gharbi, M. B., & Gharbi, J. (2013) · Molecular Biotechnology · doi:10.1007/s12033-013-9674-4 · Cited by 14
Chemical and Enzymatic Probing of Viral RNAs: From Infancy to Maturity and Beyond
Gilmer, O., Quignon, E., Jousset, A.-C., Paillart, J., Marquet, R., & Vivet‐Boudou, V. (2021) · Viruses · doi:10.3390/v13101894 · Cited by 14
“These data confirmed and completed a previous computer-predicted minimal energy structure [93] and provided additional evidence for the existence of an interaction in a region important for neurovirulence.”
ResultCalvo, T. R., Ojosnegros, S., Sanz-Ramos, M., García‐Arriaza, J., Escarmís, C., Domingo, E., & Sevilla, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010414 · Cited by 14
“One is that, because of the errorprone replication of RNA viruses, attenuated virus variants can revert to virulent forms, as extensively documented for live poliovirus vaccines [41,42,43].”
BackgroundPersistence of Foot-and-Mouth Disease Virus
Salt, J. S. (2019) · CRC Press eBooks · doi:10.1201/9780429125614-6 · Cited by 14
Baxt, B., & Rieder, E. A. (2019) · CRC Press eBooks · doi:10.1201/9780429125614-7 · Cited by 14
Selection of Coxsackievirus B4 Variants with Monoclonal Antibodies Results in Attenuation
Prabhakar, B. S., Srinivasappa, J., & Ray, U. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-3-865 · Cited by 14
Mechanism(S) of Coxsackievirus-Induced Acute Myocarditis in the Mouse
Gauntt, C. J., Godeny, E. K., Lutton, C. W., Arizpe, H. M., Crapman, N. M., Tracy, S., Revtyak, G. E., Valente, A. J., & Rozek, M. M. (1989) · Springer eBooks · doi:10.1007/978-1-4899-0891-9_10 · Cited by 14
Roberti, K. A. (1987) · Cited by 14
Quantifying low-frequency revertants in oral poliovirus vaccine using next generation sequencing
Sarcey, E., Serres, A., Tindy, F., Chareyre, A., Ng, S. H. S., Nicolas, M., Vetter, E., Bonnevay, T., Abachin, É., & Mallet, L. (2017) · Journal of Virological Methods · doi:10.1016/j.jviromet.2017.04.016 · Cited by 14
Rare adverse events associated with oral poliovirus vaccine in Brazil
Friedrich, F. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997000600001 · Cited by 14
“Since the Sabin vaccine strains may increase neurovirulence by genomic modifications during multiplication in the vaccinee and after transmission to contacts, there is also always the possibility of the appearance of neurovirulent strains erived from the Sabin vaccine strains (8,9,11,38,42-44,46-60).”
BackgroundHoriuchi, M., Yuri, K., Takehisa, S. O. M. A., Katae, H., Nagasawa, H., & Shinagawa, M. (1996) · Veterinary Microbiology · doi:10.1016/s0378-1135(96)01225-4 · Cited by 14
Ross, B. C., Anderson, B. N., Coulepis, A. G., Chenoweth, M. P., & Gust, I. D. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-8-1741 · Cited by 13
“They found only 10 base changes along the entire genome and more recently have reported that one of these changes is responsible for a near complete reversion to virulence (Evans et al., 1985).”
Background
Metadata
- Authors
- Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K., & Maizel, J. V.
- Affiliations
- National Institute for Biological Standards and Control (GB)
- University of Leicester (GB)
- National Institutes of Health (US)
- ORCID
- Cann, A. J.
- Venue
- Nature
- Published
- 1985-04
- Volume
- 314
- Issue
- 6011
- Pages
- 548-550
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2044967254
- Cited by
- 440
- References
- 17
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 12 · 2013: 7 · 2012: 3
- FWCI
- 21.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- vaccine-associated poliomyelitis, neurovirulence, point mutations, 5' untranslated region, genetic reversion, vaccine strain selection
- MeSH terms
- Base Sequence, DNA, Viral, Feces, Genes, Viral, Humans, Infant, Mutation, Nucleic Acid Conformation, Poliomyelitis, Poliovirus Vaccine, Oral, RNA, Viral, Structure-Activity Relationship, Vaccination, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.